Cross-modality deep learning model predicts tumor spread in glioblastoma, enhancing RT planning accuracy.
Motivation: To improve RT CTV definition for GBM by leveraging multi-modality bio-clinical-imaging features to uncover hidden patterns of progression. Goal(s): To develop a cross-modality deep learning model that enables precise, personalized RT planning that predicts and targets GBM tumor spread. Approach: Using a cross-modality deep learning model, we combined bio-clinical features with a diffusion-weighted, white matter path-length map. This model modified a 3D-SwinUNETR network with cross-attention to bio-clinical data and image features. Results: The cross-modality model outperformed imaging-only models, achieving higher Dice and Tversky scores, improved coverage of tumor spread, with minimal exposure to normal brain. Impact: The cross-modality approach uniquely combines bio-clinical and imaging data, capturing complex paths of tumor spread for tailored RT planning. This fusion improves prediction accuracy, minimizes healthy tissue exposure, and enhances personalized care, promising improved outcomes and extended patient survival.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: